Durham, NC · Founded 2019 · Privately Held (backing)
Developer of ocular gene therapies designed to reverse or prevent blindness. Atsena Therapeutics is based in Durham, NC and was founded in 2019. It was valued at $340 million at its later-stage round in Apr 2025, the last priced event on record. It has raised $238 million across 4 recorded rounds; the latest was a $90 million later-stage round in Mar 2025.
PMV mark · valuation
$340.0M
Oct 2026
Priced at
its later-stage round
Apr 2025
Total raised
$237.7M
Last round
Later Stage VC
Mar 2025
Team — not yet on record
No current team members for Atsena Therapeutics are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Atsena Therapeutics with a free account
·The complete investor list: 12 names
·Watch Atsena Therapeutics: the Monday email on marks, rounds and moves
